Latest News and Press Releases
Want to stay updated on the latest news?
-
PHILADELPHIA, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
-
PHILADELPHIA, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
-
PHILADELPHIA, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (NASDAQ: ALT): Grabar Law Office is investigating claims on behalf of shareholders of Altimmune, Inc. (NASDAQ: ALT). The...
-
PHILADELPHIA, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
-
PHILADELPHIA , Oct. 13, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
-
PHILADELPHIA, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
-
Kuehn Law is investigating Five Below, Inc. for potential fiduciary breaches by its officers and directors. Shareholders should contact the firm
-
Five Below, Inc. investors that lost money on their investment are encouraged to contact BFA Law before September 30, 2024 legal deadline.
-
Five Below, Inc. investors that lost money on their investment are encouraged to contact BFA Law before September 30, 2024 legal deadline.
-
Five Below, Inc. investors that lost money on their investment are encouraged to contact BFA Law before September 30, 2024 legal deadline.